Mutation analysis of WASF2 and GALE genes in one Chinese family with benign familial infantile convulsions with a novel locus.

Benign familial infantile convulsions (BFIC) are an autosomal dominant form of idiopathic epilepsy in which partial and generalized seizures commence in the first 3 months of life and spontaneously remit by age 1 year. As it is still unknown whether WASF2 and GALE genes are responsible for pure BFIC syndromes, in this article, mutations of the WASF2 and GALE genes in the proband of one Chinese family with pure BFICs were studied. Mutation analysis was carried out by polymerse chain reaction and leoxyribonueleic acid direct sequencing. One exonic variant (1047A-->G) and one intronic variant (IVS10+13A-->G), neither causing a modification of the physiologic messenger ribonucleic acid maturation, were found. The WASF2 and GALE genes do not appear to be involved in the ethiopathogenesis of pure BFIC syndromes, at least in the Chinese family we studied.
AuthorsZi Xiaohong, Mutasem Abuhamed, Wang Ya-qin
JournalJournal of investigative medicine : the official publication of the American Federation for Clinical Research (J Investig Med) Vol. 55 Issue 8 Pg. 439-43 (Dec 2007) ISSN: 1081-5589 [Print] Canada
PMID18163970 (Publication Type: Journal Article, Retracted Publication)
Chemical References
  • WASF2 protein, human
  • Wiskott-Aldrich Syndrome Protein Family
  • UDPglucose 4-Epimerase
  • Adult
  • Asian Continental Ancestry Group (genetics)
  • Base Sequence
  • DNA Mutational Analysis
  • Epilepsy, Benign Neonatal (genetics)
  • Family Health
  • Female
  • Humans
  • Infant, Newborn
  • Male
  • Pedigree
  • UDPglucose 4-Epimerase (genetics)
  • Wiskott-Aldrich Syndrome Protein Family (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: